Advertisement

Cardiac Evaluation and Management

  • Christopher Wray
  • James Y. FindlayEmail author
Chapter

Abstract

Cardiovascular assessment is an essential part of the pretransplant evaluation for liver transplantation, as cardiovascular complications are an important cause of perioperative and post-transplant morbidity and mortality. Coronary artery disease is prevalent in the population presenting for liver transplantation, and its presence has been associated with poor outcomes. Identification of occult obstructive coronary artery disease is a major part of the pretransplant evaluation. In addition, structural cardiac processes including valvular disease, cardiomyopathy, arrhythmia, and congenital heart disease may adversely impact outcomes. Recent investigations have focused on determining cardiac risk stratification in liver transplant candidates and elucidating perioperative management strategies to optimize outcomes in transplant candidates with pre-existing cardiac disease. Current coronary artery disease screening recommendations for liver transplant candidates are more heavily weighted on risk factor assessment and noninvasive testing than are those for non-transplant surgical patients. Coronary angiography has an important role in patients with positive noninvasive testing results and may also be indicated in high-risk candidates prior to listing. Management of coronary artery disease is controversial but typically includes percutaneous intervention on significant lesions. Further, perioperative treatment dilemmas are not uncommon, particularly in high-MELD or critically ill candidates. Structural cardiac disease identified via echocardiography and severe arrhythmias require cardiology consultation and possible correction prior to transplant. Programs increasingly rely on dedicated cardiology teams experienced in the pretransplant evaluation of liver transplant candidates. Likewise, liver transplant anesthesia teams provide expertise in the pretransplant evaluation of liver transplant candidates and are crucial in the evaluation of candidates with advanced cardiac disease.

Keywords

Liver transplantation Cardiac evaluation Pretransplant evaluation Coronary artery disease Valvular heart disease Arrhythmia 

References

  1. 1.
    Lentine K, Costa S, Weir M, Robb J, Fleisher L, Kasiske B, et al. Cardiac disease evaluation and management among kidney and liver transplantation candidates: a scientific statement from the American Heart Association and the American College of Cardiology Foundation. Circulation. 2012;126(5):617–63.PubMedCrossRefGoogle Scholar
  2. 2.
    Martin P, DiMartini A, Feng S, Brown R, Fallon M. Evaluation for liver transplantation in adults: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation. Hepatology. 2014;59(3):1144–65.PubMedPubMedCentralCrossRefGoogle Scholar
  3. 3.
  4. 4.
    Plotkin J, Scott V, Pinna A, Dobsch B, De Wolf A, Kang Y. Morbidity and mortality in patients with coronary artery disease undergoing orthotopic liver transplantation. Liver Transpl Surg. 1996;2(6):426–30.PubMedCrossRefGoogle Scholar
  5. 5.
    Diedrich D, Findlay J, Harrison B, Rosen C. Influence of coronary artery disease on outcomes after liver transplantation. Transplant Proc. 2008;40(10):3554–7.PubMedCrossRefGoogle Scholar
  6. 6.
    Safadi A, Homsi M, Maskoun W, Lane K, Singh I, Sawada S, et al. Perioperative risk predictors of cardiac outcomes in patients undergoing liver transplantation surgery. Circulation. 2009;120(13):1189–94.PubMedCrossRefGoogle Scholar
  7. 7.
    VanWagner L, Lapin B, Levitsky J, Wilkins J, Abecassis M, Skaro A, et al. High early cardiovascular mortality after liver transplantation. Liver Transpl. 2014;20(11):1306–16.PubMedPubMedCentralCrossRefGoogle Scholar
  8. 8.
    Gelson W, Hoare M, Dawwas M, Vowler S, Gibbs P, Alexander G. The pattern of late mortality in liver transplant recipients in the United Kingdom. Transplantation. 2011;91(11):1240–4.PubMedCrossRefGoogle Scholar
  9. 9.
    Laryea M, Watt K, Molinari M, Walsh M, McAlister V, Marotta P, et al. Metabolic syndrome in liver transplant recipients: prevalence and association with major vascular events. Liver Transpl. 2007;13(8):1109–14.PubMedCrossRefGoogle Scholar
  10. 10.
    Hogan B, Gonsalkorala E, Heneghan M. Evaluation of coronary artery disease in potential liver transplant recipients. Liver Transpl. 2017;23(3):386–95.PubMedCrossRefGoogle Scholar
  11. 11.
  12. 12.
    Tiukinhoy-Laing S, Rossi J, Bayram M, De Luca L, Gafoor S, Blei A, et al. Cardiac hemodynamic and coronary angiographic characteristics of patients being evaluated for liver transplantation. Am J Cardiol. 2006;98(2):178–81.PubMedCrossRefGoogle Scholar
  13. 13.
    Kadayifci A, Tan V, Ursell P, Merriman R, Bass N. Clinical and pathologic risk factors for atherosclerosis in cirrhosis: a comparison between NASH-related cirrhosis and cirrhosis due to other aetiologies. J Hepatol. 2008;49(4):595–9.PubMedCrossRefGoogle Scholar
  14. 14.
    Gologorsky E, Pretto E, Fukazawa K. Coronary artery disease and its risk factors in patients presenting for liver transplantation. J Clin Anesth. 2013;25(8):618–23.PubMedCrossRefGoogle Scholar
  15. 15.
    Kim W, Lake J, Smith J, Skeans M, Schladt D, et al. OPTN/SRTR 2015 annual data report: liver. Am J Transplant. 2017;17(Suppl 1):174–251.PubMedCrossRefGoogle Scholar
  16. 16.
    Fleisher L, Fleischmann K, Auerbach A, Barnason S, Beckman J, et al. ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;130:2215–45.PubMedCrossRefGoogle Scholar
  17. 17.
    Patel S, Kiefer T, Ahmed A, Ali Z, Tremmel J, et al. Comparison of the frequency of coronary artery disease in alcohol-related versus non-alcohol-related endstage liver disease. Am J Cardiol. 2011;108:1552–5.PubMedCrossRefGoogle Scholar
  18. 18.
    Moller S, Bernardi M. Interactions of the heart and the liver. Eur Heart J. 2013;34:2804–11.PubMedCrossRefPubMedCentralGoogle Scholar
  19. 19.
    Plotkin J, Benitez R, Kuo P, Njoku M, Ridge L, et al. Dobutamine stress echocardiography for preoperative cardiac risk stratification in patients undergoing orthotopic liver transplantation. Liver Transpl Surg. 1998;4:253–7.PubMedCrossRefPubMedCentralGoogle Scholar
  20. 20.
    Snipelisky D, Levy M, Shapiro B. Utility of dobutamine stress echocardiography as part of the pre-liver transplant evaluation: an evaluation of its efficacy. Clin Cardiol. 2014;37:468–72.PubMedCrossRefPubMedCentralGoogle Scholar
  21. 21.
    Harinstein M, Flaherty J, Ansari A, Robin J, Davidson C, et al. Predictive value of dobutamine stress echocardiography for coronary artery disease detection in liver transplant candidates. Am J Transplant. 2008;8:1523–8.PubMedCrossRefPubMedCentralGoogle Scholar
  22. 22.
    Singhal A, Mukerji A, Thomaides A, Karachristos A, Maloo M, et al. Chronotropic incompetence on dobutamine stress echocardiography in candidates for a liver transplant. Exp Clin Transplant. 2013;11:546–53.PubMedCrossRefPubMedCentralGoogle Scholar
  23. 23.
    Nguyen P, Plotkin J, Fishbein T, Lauren J, Satoskar R, et al. Dobutamine stress echocardiography in patients undergoing orthotopic liver transplantation: a pooled analysis of accuracy, perioperative and long term cardiovascular prognosis. Int J Cardiovasc Imaging. 2013;29(8):1741–8.PubMedCrossRefPubMedCentralGoogle Scholar
  24. 24.
    Aydinalp A, Bal U, Atar I, Urtan C, Yildirir A, et al. Value of stress myocardial perfusion scanning in diagnosis of severe coronary artery disease in liver transplantation candidates. Transplant Proc. 2009;41(9):3757–60.PubMedCrossRefPubMedCentralGoogle Scholar
  25. 25.
    Senzolo M, Bassanello M, Graziotto A, Zucchetta P, Cillo U, et al. Microvascular autonomic dysfunction may justify false-positive stress myocardial perfusion imaging in patients with liver cirrhosis undergoing liver transplantation. Transplant Proc. 2008;40(6):1916–7.PubMedCrossRefPubMedCentralGoogle Scholar
  26. 26.
    Bhutani S, Tobis J, Gevorgyan R, Sinha A, Suh W, et al. Accuracy of stress myocardial perfusion imaging to diagnose coronary artery disease in end stage liver disease patients. Am J Cardiol. 2013;111(7):1057–61.PubMedCrossRefPubMedCentralGoogle Scholar
  27. 27.
    Kemmer N, Case J, Chandna S, Neff G. The role of coronary calcium score in the risk assessment of liver transplant candidates. Transplant Proc. 2014;46(1):230–3.PubMedCrossRefPubMedCentralGoogle Scholar
  28. 28.
    Poulin M, Chan E, Doukky R. Coronary computed tomographic angiography in the evaluation of liver transplant candidates. Angiology. 2015;66(9):803–10.PubMedCrossRefPubMedCentralGoogle Scholar
  29. 29.
    Pillarisetti J, Patel P, Duthuluru S, Roberts J, Chen W, et al. Cardiac catheterization in patients with end-stage liver disease: safety and outcomes. Catheterization Cardiovasc Intervent. 2011;77(1):45–8.CrossRefGoogle Scholar
  30. 30.
    Sharma M, Yong C, Majure D, Zellner C, Roberts J, et al. Safety of cardiac catheterization in patients with end-stage liver disease awaiting liver transplantation. Am J Cardiol. 2009;103(5):742–6.PubMedCrossRefGoogle Scholar
  31. 31.
    Jacobs E, Singh V, Damluji A, Shah N, Warsch J, et al. Safety of transradial cardiac catheterization in patients with end-stage liver disease. Catheterization Cardiovasc Intervent. 2014;83(3):360–6.CrossRefGoogle Scholar
  32. 32.
    Shantouf R, Mehra A. Coronary fractional flow reserve. Am J Roentgenol. 2015;204(3):261–5.CrossRefGoogle Scholar
  33. 33.
    Levine G, Bates E, Bittl J, Brindis R, Fihn S, et al. ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease. J Am Coll Cardiol. 2016;68(10):1082–115.PubMedCrossRefGoogle Scholar
  34. 34.
    Shaheen A, Kaplan G, Hubbard J, Myers R. Morbidity and mortality following coronary artery bypass graft surgery in patients with cirrhosis: a population-based study. Liver Int. 2009;29(8):1141–51.PubMedCrossRefGoogle Scholar
  35. 35.
    Filsoufi F, Salzberg S, Rahmanian P, Schiano T, Elsiesy H, et al. Early and late outcome of cardiac surgery in patients with liver cirrhosis. Liver Transpl. 2007;13(7):990–5.PubMedCrossRefGoogle Scholar
  36. 36.
    Hayashida N, Shoujima T, Teshima H, Yokokura Y, Takagi K, et al. Clinical outcome after cardiac operations in patients with cirrhosis. Ann Thorac Surg. 2004;77(2):500–5.PubMedCrossRefGoogle Scholar
  37. 37.
    Giakoustidis A, Cherian T, Antoniadis N, Giakoustidis D. Combined cardiac surgery and liver transplantation: three decades of worldwide results. J Gastrointestin Liver Dis. 2011;20(4):415–21.PubMedGoogle Scholar
  38. 38.
    Milan Z, Taylor C, Armstrong D, Davies P, Roberts S, et al. Does preoperative Beta-blocker use influence intraoperative hemodynamic profile and post-operative course of liver transplantation? Transplant Proc. 2016;48(1):111–5.PubMedCrossRefGoogle Scholar
  39. 39.
    Maddur H, Bourdillon P, Liangpunsakul S, Joseph Tector A, Fridell A, et al. Role of cardiac catheterization and percutaneous coronary intervention in the preoperative assessment and management of patients before orthotopic liver transplantation. Liver Transpl. 2014;20(6):664–72.PubMedCrossRefPubMedCentralGoogle Scholar
  40. 40.
    Satapathy S, Vanatta J, Helmick R, Flowers A, Kedia S, et al. Outcome of liver transplant recipients with Revascularized coronary artery disease: a comparative analysis with and without cardiovascular risk factors. Transplantation. 2017;101(4):793–803.PubMedCrossRefPubMedCentralGoogle Scholar
  41. 41.
    Skaro A, Gallon L, Lyuksemburg V, Jay C, Ladner D, et al. The impact of coronary artery disease on outcomes after liver transplantation. J Cardiovasc Med (Hagerstown). 2016;17(12):875–85.CrossRefGoogle Scholar
  42. 42.
    Wray C, Scovotti J, Tobis J, Niemann C, Planinsic R, et al. Liver transplantation outcome in patients with angiographically proven coronary artery disease: a multi-institutional study. Am J Transplant. 2013;13(1):184–91.PubMedCrossRefGoogle Scholar
  43. 43.
    Alexopoulos S, Matsuoka L, Cho Y, Thomas E, Sheikh M, et al. Outcomes after liver transplantation in patients achieving a model for end-stage liver disease score of 40 or higher. Transplantation. 2013;95(3):507–12.PubMedCrossRefGoogle Scholar
  44. 44.
    Kaltenborn A, Hartmann C, Salinas R, Ramackers W, Kleine M, et al. Risk factors for short- and long-term mortality in liver transplant recipients with MELD score >/=30. Ann Transplant. 2015;20:59–69.PubMedCrossRefGoogle Scholar
  45. 45.
    Onaca N, Levy M, Sanchez E, Chinnakotia S, Fasola C, et al. A correlation between the pretransplantation MELD score and mortality in the first two years after liver transplantation. Liver Transpl. 2003;9(3):117–23.PubMedCrossRefGoogle Scholar
  46. 46.
    Petrowsky H, Rana A, Kaldas F, Sharma A, Hong J, et al. Liver transplantation in highest acuity recipients: identifying factors to avoid futility. Ann Surg. 2014;259(6):1186–94.PubMedCrossRefGoogle Scholar
  47. 47.
    Kertai MD, Bountioukos M, Boersma E, Bax JJ, Thomson IR, Sozzi F, et al. Aortic stenosis: an underestimated risk factor for perioperative complications in patients undergoing noncardiac surgery. Am J Med. 2004;116(1):8–13.PubMedCrossRefGoogle Scholar
  48. 48.
    Thielmann M, Mechmet A, Neuhauser M, Wendt D, Tossios P, Canbay A, et al. Risk prediction and outcomes in patients with liver cirrhosis undergoing open-heart surgery. Eur J Cardiothorac Surg. 2010;38(5):592–9.PubMedCrossRefGoogle Scholar
  49. 49.
    Eckhoff DE, Frenette L, Sellers MT, McGuire BM, Contreras JL, Bynon JS, et al. Combined cardiac surgery and liver transplantation. Liver Transpl. 2001;7(1):60–1.PubMedCrossRefGoogle Scholar
  50. 50.
    Parker BM, Mayes JT, Henderson JM, Savage RM. Combined aortic valve replacement and orthotopic liver transplantation. J Cardiothorac Vasc Anesth. 2001;15(4):474–6.PubMedCrossRefPubMedCentralGoogle Scholar
  51. 51.
    Kalarickal P, Liu Q, Rathor R, Ishag S, Kerr T, Kangrga I. Balloon aortic valvuloplasty as a bridge to liver transplantation in patients with severe aortic stenosis: a case series. Transplant Proc. 2014;46(10):3492–5.PubMedCrossRefPubMedCentralGoogle Scholar
  52. 52.
    Silvestre OM, Bacal F, Ramos DS, Tarasoutchi F, Acorsi TD, Fernandes F, et al. Transcatheter aortic valve implantation as rescue therapy for liver transplant candidates with aortic valve stenosis. Liver Transpl. 2014;20(10):1277–9.PubMedCrossRefPubMedCentralGoogle Scholar
  53. 53.
    Moreno R, Delcan JL, Garcia E, Villacastin J, Ortega A, Perez E. Emergent mitral percutaneous valvuloplasty before emergent liver transplantation. Catheter Cardiovasc Diagn. 1997;41(2):229–30.CrossRefGoogle Scholar
  54. 54.
    Navasa M, Feu F, Garcia-Pagan JC, Jimenez W, Llach J, Rimola A, et al. Hemodynamic and humoral changes after liver transplantation in patients with cirrhosis. Hepatology. 1993;17(3):355–60.PubMedCrossRefGoogle Scholar
  55. 55.
    Alper I, Ulukaya S, Demir F, Kilic M. Effects of cardiac valve dysfunction on perioperative management of liver transplantation. Transplant Proc. 2009;41(5):1722–6.PubMedCrossRefGoogle Scholar
  56. 56.
    Kia L, Shah SJ, Wang E, Sharma D, Selvaraj S, Medina C, et al. Role of pretransplant echocardiographic evaluation in predicting outcomes following liver transplantation. Am J Transplant. 2013;13(9):2395–401.PubMedCrossRefGoogle Scholar
  57. 57.
    Maraj S, Jacobs LE, Maraj R, Contreras R, Rerkpattanapipat P, Malik TA, et al. Inducible left ventricular outflow tract gradient during dobutamine stress echocardiography: an association with intraoperative hypotension but not a contraindication to liver transplantation. Echocardiography. 2004;21(8):681–5.PubMedCrossRefGoogle Scholar
  58. 58.
    Harley ID, Jones EF, Liu G, McCall PR, McNicol PL. Orthotopic liver transplantation in two patients with hypertrophic obstructive cardiomyopathy. Br J Anaesth. 1996;77(5):675–7.PubMedCrossRefGoogle Scholar
  59. 59.
    Hensley N, Dietrich J, Nyhan D, Mitter N, Yee MS, Brady M. Hypertrophic cardiomyopathy: a review. Anesth Analg. 2015;120(3):554–69.PubMedCrossRefGoogle Scholar
  60. 60.
    Paramesh AS, Fairchild RB, Quinn TM, Leya F, George M, Van Thiel DH. Amelioration of hypertrophic cardiomyopathy using nonsurgical septal ablation in a cirrhotic patient prior to liver transplantation. Liver Transpl. 2005;11(2):236–8.PubMedCrossRefPubMedCentralGoogle Scholar
  61. 61.
    Meissner I, Whisnant JP, Khandheria BK, Spittell PC, O'Fallon WM, Pascoe RD, et al. Prevalence of potential risk factors for stroke assessed by transesophageal echocardiography and carotid ultrasonography: the SPARC study. Stroke Prevent: Assessment Risk Commun Mayo Clin Proc. 1999;74(9):862–9.Google Scholar
  62. 62.
    Alba AC, Verocai Flaman F, Granton J, Delgado DH. Patent foramen ovale does not have a negative impact on early outcomes in patients undergoing liver transplantation. Clin Transpl. 2011;25(1):151–5.CrossRefGoogle Scholar
  63. 63.
    Werlang ME, Palmer WC, Boyd EA, Cangemi DJ, Harnois DM, Taner CB, et al. Patent foramen ovale in liver transplant recipients does not negatively impact short-term outcomes. Clin Transpl. 2016;30(1):26–32.CrossRefGoogle Scholar
  64. 64.
    Concejero A, Chen CL, Liang CD, Wang CC, Wang SH, Lin CC, et al. Atrial septal defect in end-stage liver disease children before and after liver transplantation. Surgery. 2008;143(2):271–7.PubMedCrossRefPubMedCentralGoogle Scholar
  65. 65.
    Tam NL, Concejero AM, Liang CD. Fate of atrial septal defect in children with end-stage liver disease undergoing living donor liver transplantation. Transplant Proc. 2008;40(8):2510–1.PubMedCrossRefPubMedCentralGoogle Scholar
  66. 66.
    Asrani SK, Asrani NS, Freese DK, Phillips SD, Warnes CA, Heimbach J, et al. Congenital heart disease and the liver. Hepatology. 2012;56(3):1160–9.PubMedCrossRefPubMedCentralGoogle Scholar
  67. 67.
    D'Souza BA, Fuller S, Gleason LP, Hornsby N, Wald J, Krok K, et al. Single-center outcomes of combined heart and liver transplantation in the failing Fontan. Clin Transpl. 2017;31(3)CrossRefGoogle Scholar
  68. 68.
    Moller S, Henriksen JH. Cardiovascular complications of cirrhosis. Gut. 2008;57(2):268–78.PubMedCrossRefPubMedCentralGoogle Scholar
  69. 69.
    Zardi EM, Abbate A, Zardi DM, Dobrina A, Margiotta D, Van Tassell BW, et al. Cirrhotic cardiomyopathy. J Am Coll Cardiol. 2010;56(7):539–49.PubMedCrossRefPubMedCentralGoogle Scholar
  70. 70.
    Rahman S, Mallett SV. Cirrhotic cardiomyopathy: implications for the perioperative management of liver transplant patients. World J Hepatol. 2015;7(3):507–20.PubMedPubMedCentralCrossRefGoogle Scholar
  71. 71.
    Torregrosa M, Aguade S, Dos L, Segura R, Gonzalez A, Evangelista A, et al. Cardiac alterations in cirrhosis: reversibility after liver transplantation. J Hepatol. 2005;42(1):68–74.PubMedCrossRefGoogle Scholar
  72. 72.
    Raevens S, De Pauw M, Geerts A, Berrevoet F, Rogiers X, Troisi RI, et al. Prevalence and outcome of diastolic dysfunction in liver transplantation recipients. Acta Cardiol. 2014;69(3):273–80.PubMedCrossRefGoogle Scholar
  73. 73.
    Merli M, Calicchia A, Ruffa A, Pellicori P, Riggio O, Giusto M, et al. Cardiac dysfunction in cirrhosis is not associated with the severity of liver disease. Eur J Intern Med. 2013;24(2):172–6.PubMedCrossRefGoogle Scholar
  74. 74.
    Pozzi M, Carugo S, Boari G, Pecci V, de Ceglia S, Maggiolini S, et al. Evidence of functional and structural cardiac abnormalities in cirrhotic patients with and without ascites. Hepatology. 1997;26(5):1131–7.PubMedGoogle Scholar
  75. 75.
    Sampaio F, Pimenta J, Bettencourt N, Fontes-Carvalho R, Silva AP, Valente J, et al. Systolic dysfunction and diastolic dysfunction do not influence medium-term prognosis in patients with cirrhosis. Eur J Intern Med. 2014;25(3):241–6.PubMedCrossRefGoogle Scholar
  76. 76.
    Alexopoulou A, Papatheodoridis G, Pouriki S, Chrysohoou C, Raftopoulos L, Stefanadis C, et al. Diastolic myocardial dysfunction does not affect survival in patients with cirrhosis. Transpl Int. 2012;25(11):1174–81.PubMedCrossRefGoogle Scholar
  77. 77.
    Mittal C, Qureshi W, Singla S, Ahmad U, Huang MA. Pre-transplant left ventricular diastolic dysfunction is associated with post transplant acute graft rejection and graft failure. Dig Dis Sci. 2014;59(3):674–80.PubMedCrossRefGoogle Scholar
  78. 78.
    Escobar B, Taura P, Martinez-Palli G, Fondevila C, Balust J, Beltran J, et al. Stroke volume response to liver graft reperfusion stress in cirrhotic patients. World J Surg. 2014;38(4):927–35.PubMedCrossRefGoogle Scholar
  79. 79.
    Moller S, Henriksen J. Cirrhotic cardiomyopathy. J Hepatol. 2010;53(1):179–90.PubMedCrossRefGoogle Scholar
  80. 80.
    Trevisani F, Merli M, Savelli F, Valeriono V, Zambruni A, et al. QT interval in patients with non-cirrhotic portal hypertension and in cirrhotic patients treated with transjugular intrahepatic porto-systemic shunt. J Hepatol. 2003;38(3):461–7.PubMedCrossRefPubMedCentralGoogle Scholar
  81. 81.
    Bernardi M, Maggioli C, Dibra V, Zaccherini G. QT interval prolongation in liver cirrhosis: innocent bystander or serious threat. Expert Rev Gastroenterol Hepatol. 2012;6(1):57–66.PubMedCrossRefPubMedCentralGoogle Scholar
  82. 82.
    Chung E, Jeon Y, Kim H, Lee K, Lee J, et al. Torsade de pointes in liver transplantation recipient after induction of general anesthesia: a case report. Korean J Anesthesiol. 2014;66(1):80–4.PubMedPubMedCentralCrossRefGoogle Scholar
  83. 83.
    Kim M, Kim N, Park J, Nam S. Ventricular arrhythmia in patients with prolonged QT interval during liver transplantation: two cases report. Korean J Anesthesiol. 2014;67(6):416–20.PubMedPubMedCentralCrossRefGoogle Scholar
  84. 84.
    Chin J, Park J, Kim S, Kim S, Kong Y, et al. Torsades de pointes triggered by severe diastolic hypotension with low hematocrit in the Neohepatic stage of liver transplantation: a case report. Transplant Proc. 2010;42(5):1959–62.PubMedCrossRefPubMedCentralGoogle Scholar
  85. 85.
    Gwak M, Kim J, Kim G, Choi S, Ahn H, et al. Incidence of severe ventricular arrhythmias during pulmonary artery catheterization in liver allograft recipients. Liver Transpl. 2007;13(10):1451–4.PubMedCrossRefPubMedCentralGoogle Scholar
  86. 86.
    Eleid M, Hurst T, Vargas H, Rakela J, Mulligan D, et al. Short-term cardiac and noncardiac mortality following liver transplantation. J Transplant. 2010;7:Article ID 910165.  https://doi.org/10.1155/2010/910165.CrossRefGoogle Scholar
  87. 87.
    Nicolau-Raducu R, Gitman M, Ganier D, Loss G, Cohen A, et al. Adverse cardiac events after orthotopic liver transplantation: a cross-sectional study in 389 consecutive patients. Liver Transpl. 2015;21(1):13–21.PubMedCrossRefGoogle Scholar
  88. 88.
    Josefsson A, Fu M, Björnsson E, Kalaitzakis E. Prevalence of pre-transplant electrocardiographic abnormalities and post-transplant cardiac events in patients with liver cirrhosis. Bio Med Central Gastroenterol. 2014;14:65.  https://doi.org/10.1186/1471-230X-14-65. 11 pagesCrossRefGoogle Scholar
  89. 89.
    January C, Wann L, Alpert J, Calkins H, Cigarroa J, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation a report of the American College of Cardiology/American Heart Association task force on practice guidelines and the Heart Rhythm Society. Circulation. 2014;130(23):e199–267.PubMedPubMedCentralGoogle Scholar
  90. 90.
    Bargehr J, Trejo-Gutierrez J, Patel T, Rosser B, Aranda-Michel J, et al. Preexisting atrial fibrillation and cardiac complications after liver transplantation. Liver Transpl. 2015;21(3):314–20.PubMedCrossRefPubMedCentralGoogle Scholar
  91. 91.
    Vannucci A, Rathor R, Vachharajani N, Chapman W, Kangrga I. Atrial fibrillation in patients undergoing liver transplantation-a single-center experience. Transplant Proceed. 2014;46(5):1432–7.CrossRefGoogle Scholar
  92. 92.
    Xia V, Worapot A, Huang S, Dhillon A, Gudzenko V, et al. Postoperative atrial fibrillation in liver transplantation. Am J Transplant. 2015;15(3):687–94.PubMedCrossRefPubMedCentralGoogle Scholar
  93. 93.
    Vallurupalli S, Shanbhag A, Mehta J. Controversies in postoperative atrial fibrillation after noncardiothoracic surgery: clinical and research implications. Clin Cardiol. 2017;40(5):329–32.PubMedCrossRefPubMedCentralGoogle Scholar
  94. 94.
    Fede G, Privitera G, Tomaselli T, Spadaro L, Purrello F. Cardiovascular dysfunction in patients with liver cirrhosis. Ann Gastroenterol. 2015;28(1):31–40.PubMedPubMedCentralGoogle Scholar
  95. 95.
    Ates F, Topal E, Kosar F, Karincaoglu M, Yildirim B, et al. The relationship of heart rate variability with severity and prognosis of cirrhosis. Dig Dis Sci. 2006;51(9):1614–8.PubMedCrossRefPubMedCentralGoogle Scholar
  96. 96.
    Siniscalchi A, Gamberini L, Laici C, Bardi T, Ercolani G, et al. Post reperfusion syndrome during liver transplantation: from pathophysiology to therapy and preventive strategies. World J Gastroenterol. 2016;22(4):1551–69.PubMedPubMedCentralCrossRefGoogle Scholar
  97. 97.
    Kobayashi T, Sato Y, Yamamoto S, Oya H, Takeishi T, et al. Temporary cardiac pacing for fatal arrhythmia in living-donor liver transplantation: three case reports. Transplant Proc. 2008;40(8):2818–20.PubMedCrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Liver Transplant Division, Department of Anesthesiology and Perioperative MedicineRonald Reagan UCLA Medical CenterLos AngelesUSA
  2. 2.Solid Organ Transplant Anesthesia, Department of Anesthesiology and Perioperative MedicineMayo ClinicRochesterUSA

Personalised recommendations